Study of Personalized Cancer Therapy to Determine Response and Toxicity

Launched by SHU MEI KATO · Jun 18, 2015

Keywords

ClinConnect Summary

This clinical trial is studying how personalized cancer therapy works, focusing on how well patients respond to treatment and what side effects they might experience. Researchers want to find out if patients do better when their doctors choose treatments based on the specific genetic characteristics of their tumors. To do this, they will gather information from medical records and may conduct additional tests on samples like tissue, blood, or urine that are typically discarded during regular care. These tests will help create a detailed picture of the genes involved in each patient's cancer and look for markers that might predict how well the treatment will work.

To participate, individuals must be willing to give consent or permission, and the trial is open to all genders and ages starting from 25 and up. Participants can expect to provide some samples and information about their previous treatments, and they will play a role in advancing the understanding of personalized cancer therapy, potentially benefiting future patients. If you are interested in joining this study, please talk to your healthcare provider for more details.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Must be willing to provide informed consent, parent permission, or assent
• Exclusion Criteria:
• • Subjects unable to give informed consent, parent permission, or assent